Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects

Atopic dermatitis (AD) is a common, complex trait, arising from the interplay of multiple genetic and environmental factors. This review provides an overview of developments in the field of AD genetics. AD shows high heritability; strategies to investigate genetic risk include linkage, candidate gen...

Full description

Bibliographic Details
Main Authors: Sara J. Brown, Martina S. Elias, Maria Bradley
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2020-06-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3513
id doaj-18e78ef3670e45869781bf9d6c2879a8
record_format Article
spelling doaj-18e78ef3670e45869781bf9d6c2879a82020-11-25T03:41:05ZengSociety for Publication of Acta Dermato-VenereologicaActa Dermato-Venereologica0001-55551651-20572020-06-0110012adv0016310.2340/00015555-35135768Genetics in Atopic Dermatitis: Historical Perspective and Future ProspectsSara J. Brown0Martina S. EliasMaria Bradley Skin Research Group, Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, DD1 9SY Dundee, United Kingdom. E-mail: s.j.brown@dundee.ac.uk. Atopic dermatitis (AD) is a common, complex trait, arising from the interplay of multiple genetic and environmental factors. This review provides an overview of developments in the field of AD genetics. AD shows high heritability; strategies to investigate genetic risk include linkage, candidate gene studies, genome-wide association and animal modelling. Loss-of-function mutations in FLG, encoding the skin barrier protein filaggrin, remain the strongest genetic risk factor identified for AD, but variants influencing skin and systemic immune function are also important. AD is at the forefront of genetic research, from large-scale population studies to in vitro models and detailed molecular analyses. An understanding of genetic risk factors has considerably improved knowledge of mechanisms leading to atopic skin inflammation. Together this work has identified avenues for therapeutic intervention, but further research is needed to fully realise the opportunities of personalised medicine for this complex disease, to optimise patient benefit. https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3513 atopic dermatitis eczema filaggrin genetic genome-wide risk phenotype transcriptome
collection DOAJ
language English
format Article
sources DOAJ
author Sara J. Brown
Martina S. Elias
Maria Bradley
spellingShingle Sara J. Brown
Martina S. Elias
Maria Bradley
Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
Acta Dermato-Venereologica
atopic dermatitis
eczema
filaggrin
genetic
genome-wide
risk
phenotype
transcriptome
author_facet Sara J. Brown
Martina S. Elias
Maria Bradley
author_sort Sara J. Brown
title Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
title_short Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
title_full Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
title_fullStr Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
title_full_unstemmed Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
title_sort genetics in atopic dermatitis: historical perspective and future prospects
publisher Society for Publication of Acta Dermato-Venereologica
series Acta Dermato-Venereologica
issn 0001-5555
1651-2057
publishDate 2020-06-01
description Atopic dermatitis (AD) is a common, complex trait, arising from the interplay of multiple genetic and environmental factors. This review provides an overview of developments in the field of AD genetics. AD shows high heritability; strategies to investigate genetic risk include linkage, candidate gene studies, genome-wide association and animal modelling. Loss-of-function mutations in FLG, encoding the skin barrier protein filaggrin, remain the strongest genetic risk factor identified for AD, but variants influencing skin and systemic immune function are also important. AD is at the forefront of genetic research, from large-scale population studies to in vitro models and detailed molecular analyses. An understanding of genetic risk factors has considerably improved knowledge of mechanisms leading to atopic skin inflammation. Together this work has identified avenues for therapeutic intervention, but further research is needed to fully realise the opportunities of personalised medicine for this complex disease, to optimise patient benefit.
topic atopic dermatitis
eczema
filaggrin
genetic
genome-wide
risk
phenotype
transcriptome
url https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3513
work_keys_str_mv AT sarajbrown geneticsinatopicdermatitishistoricalperspectiveandfutureprospects
AT martinaselias geneticsinatopicdermatitishistoricalperspectiveandfutureprospects
AT mariabradley geneticsinatopicdermatitishistoricalperspectiveandfutureprospects
_version_ 1724531922679365632